Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes

Completed

• Conditions: Insulin Resistance

• Registration Number: NCT00186004
• Lead Sponsor: Stanford University

Brief Summary

We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.

Detailed Description

Patients are recruited for 3 day continuous glucose monitoring (CGM) plus self-blood glucose monitoring followed by routine diabetes screening at 26-28 weeks gestation to determine if maternal blood glucose excursions correlate with deviation from optimized birth weight.

Study Timeline

• Study Start: 2002-12
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-16
• Primary Completion: 2006-09
• Study Completion: 2008-05
• Status Verified: 2011-06
• Last Update Submitted: 2011-06-13
• Last Update Posted: 2011-06-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 21

Inclusion Criteria

• Pregnant patients under 28 weeks gestation

Exclusion Criteria

• Pre-gestational diabetes

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Birthweight centile	Delivery

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States